サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1279776

変形性関節症治療薬の世界市場規模調査＆予測、薬剤タイプ別、生体構造別、流通チャネル別、地域別分析、2022-2029年

Global Osteoarthritis Therapeutics Market Size study & Forecast, by Anatomy by Drug Type, by Distribution Channel and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
変形性関節症治療薬の世界市場規模調査＆予測、薬剤タイプ別、生体構造別、流通チャネル別、地域別分析、2022-2029年
出版日: 2023年05月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の変形性関節症治療薬市場は、2021年に約73億4,846万米ドルと評価され、予測期間2022-2029年には8.8%以上の健全な成長率で成長すると予測されています。

最も一般的な慢性健康障害の1つである変形性関節症は、持続的な痛み、機能障害、運動能力の低下によって特徴付けられます。変形性関節症は、時間の経過とともに悪化する関節の退行性疾患で、1つまたは複数の関節の軟骨が劣化し、最終的に失われることによって引き起こされます。軟骨の例としては、膝、足首、肘などの骨と骨の間にある関節に存在します。軟骨は、関節を潤滑にし、摩擦を軽減する働きがあります。変形性関節症の治療は、痛みを軽減し、機能的な状態を改善することを目的としています。変形性関節症治療薬市場は、変形性関節症の有病率の増加や変形性関節症に罹患しやすい人口の増加などの要因により、拡大しています。

米国疾病対策センター（Centers for Disease Control and Prevention）によると、2020年に米国で関節炎と診断された人は約6300万人であり、2045年には7800万人に達すると予想されています。このように、変形性関節症の患者数は増加傾向にあり、市場の成長を後押ししています。Journal of EClinical Medicine誌は、2020年に、世界の40歳以上の人々の約22％が変形性膝関節症と診断されたと述べています。世界銀行グループによると、世界の老年人口は2020年に7億2700万人でしたが、今後30年間で3倍に増え、2050年には15億人に達すると予測されています。このように、この地域における老年人口の増加は、市場の成長をさらに加速させるものです。また、スポーツ傷害の増加や変形性関節症に対する個別化医薬品の開発が、市場に有利な成長をもたらしています。しかし、変形性関節症治療におけるNSAIDsの使用に伴う有害な心血管イベントのリスクや、代替品の商業化が市場成長の妨げになる可能性があります。

変形性関節症治療薬の世界市場調査において考慮した主要地域は、アジア太平洋地域、北米、欧州、中南米、その他世界の地域です。北米は、主要な市場プレイヤーの優位性とこの地域の疾患有病率の増加により、収益面で市場を独占しています。一方、アジア太平洋は、老年人口および対象人口の増加、製品開拓のための共同研究の増加、主要企業の地域的拡大、政府機関や非営利団体の市場参入などの要因により、予測期間中に最高のCAGRで成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメント＆国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、競合情勢や主要企業の提供するサービスの詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推計・予測、2019年～2029年
    • 変形性関節症治療薬市場、地域別、2019-2029年
    • 変形性関節症治療薬市場：生体構造別、2019年-2029年
    • 変形性関節症治療薬市場、薬剤タイプ別、2019-2029年
    • 変形性関節症治療薬市場：流通チャネル別、2019年-2029年
  • 主な動向
  • 予測手法
  • 調査の前提条件

第2章 変形性関節症治療薬の世界市場定義とスコープ

  • 本調査の目的
  • 市場の定義とスコープ
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 変形性関節症治療薬の世界市場力学

  • 変形性関節症治療薬市場のインパクト分析（2019年～2029年）
    • 市場促進要因
      • 変形性関節症の有病率の増加
      • 変形性関節症に罹患しやすい人口の増加
    • 市場の課題
      • NSAIDsの使用に伴う心血管系有害事象のリスク
      • 代替品の商業化
    • 市場機会
      • スポーツ傷害の増加
      • 個別化医薬品の開発

第4章 変形性関節症治療薬の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルの未来的アプローチ（2019年～2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • トップ投資機会
  • 主要成功戦略
  • 業界専門家別展望
  • アナリストの結論・提言

第5章 リスクアセスメントCOVID-19のインパクト

  • COVID-19が業界に与える全体的な影響についてのアセスメント
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 変形性関節症治療薬の世界市場：生体構造別

  • 市場スナップショット
  • 変形性関節症治療薬の世界市場：生体構造分野別、実績-ポテンシャル分析
  • 変形性関節症治療薬の世界市場生体構造別推定・予測2019～2029年
  • 変形性関節症治療薬市場、サブセグメント分析
    • 膝変形性関節症
    • 変形性股関節症
    • 手の変形性関節症
    • 小関節変形性関節症

第7章 変形性関節症治療薬の世界市場：薬剤タイプ別

  • 市場スナップショット
  • 変形性関節症治療薬の世界市場：薬物タイプ別、実績-ポテンシャル分析
  • 変形性関節症治療薬の世界市場、薬剤タイプ別推定・予測2019-2029
  • 変形性関節症治療薬市場、サブセグメント別分析
    • 関節内補充療法薬
    • 非ステロイド性抗炎症薬
    • 鎮痛剤
    • 副腎皮質ホルモン剤

第8章 変形性関節症治療薬の世界市場：流通チャネル別

  • 市場スナップショット
  • 変形性関節症治療薬の世界市場：流通チャネル別、実績-ポテンシャル分析
  • 変形性関節症治療薬の世界市場、流通チャネル別推定・予測2019年～2029年
  • 変形性関節症治療薬市場、サブセグメント別分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第9章 変形性関節症治療薬の世界市場：地域別分析

  • 変形性関節症治療薬市場、地域別市場スナップショット
  • 北米
    • 米国
      • 生体構造別の推定・予測、2019年～2029年
      • 薬剤タイプ別の推定・予測、2019年～2029年
      • 流通チャネル別の推定・予測、2019年～2029年
    • カナダ
  • 欧州の変形性関節症治療薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域の変形性関節症治療薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの変形性関節症治療薬市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Pfizer, Inc
      • 主要情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の開発状況
    • Eli Lilly and Company
    • Horizon Therapeutics plc
    • Ferring B.V.
    • Merck Sharp & Dohme Corp.
    • GlaxoSmithKline Plc.
    • Johnson & Johnson Private Limited
    • Bayer AG
    • Novartis AG
    • Pacira Pharmaceuticals, Inc

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Osteoarthritis Therapeutics Market, report scope
  • TABLE 2. Global Osteoarthritis Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Osteoarthritis Therapeutics Market estimates & forecasts by Anatomy 2019-2029 (USD Million)
  • TABLE 4. Global Osteoarthritis Therapeutics Market estimates & forecasts by Drug Type 2019-2029 (USD Million)
  • TABLE 5. Global Osteoarthritis Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
  • TABLE 6. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. U.S. Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. Canada Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 20. Canada Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. Canada Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. UK Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 23. UK Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. UK Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. Germany Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 26. Germany Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. Germany Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. France Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 29. France Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. France Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. Italy Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 32. Italy Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Italy Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Spain Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 35. Spain Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. Spain Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. RoE Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 38. RoE Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. RoE Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. China Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 41. China Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. China Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. India Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 44. India Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. India Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. Japan Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 47. Japan Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. Japan Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. South Korea Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 50. South Korea Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. South Korea Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. Australia Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 53. Australia Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. Australia Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. Brazil Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 59. Brazil Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Brazil Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Mexico Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 62. Mexico Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. Mexico Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. RoLA Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 65. RoLA Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. RoLA Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. Row Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 68. Row Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. Row Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global Osteoarthritis Therapeutics Market
  • TABLE 71. List of primary sources, used in the study of global Osteoarthritis Therapeutics Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Osteoarthritis Therapeutics Market, research methodology
  • FIG 2. Global Osteoarthritis Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Osteoarthritis Therapeutics Market, key trends 2021
  • FIG 5. Global Osteoarthritis Therapeutics Market, growth prospects 2022-2029
  • FIG 6. Global Osteoarthritis Therapeutics Market, porters 5 force model
  • FIG 7. Global Osteoarthritis Therapeutics Market, pest analysis
  • FIG 8. Global Osteoarthritis Therapeutics Market, value chain analysis
  • FIG 9. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Osteoarthritis Therapeutics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
  • FIG 19. Global Osteoarthritis Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Osteoarthritis Therapeutics Market is valued approximately USD 7348.46 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.8% over the forecast period 2022-2029. One of the most prevalent chronic health disorders, osteoarthritis is characterised by persistent pain, impairment, and decreased mobility. It is a degenerative condition of the joints that worsens with time and is brought on by the deterioration and eventual loss of cartilage in one or more joints. An example of cartilage is present in the joints between bones include the knee, ankle, and elbow. It assists in lubricating the joint and lowering friction. Treatment for osteoarthritis aims to reduce pain and improve functional status. The Osteoarthritis Therapeutics market is expanding because of factors such as Increasing prevalence of osteoarthritis and Growing population susceptible to osteoarthritis.

According to Centers for Disease Control and Prevention, in year 2020, there were around 63 million people in US had diagnosed with arthritis which is expected to reach at 78 million by year 2045. Thus rising prevelance of osteoarthritis is propelling the market growth. The Journal of EClinical Medicine stated in 2020 that roughly 22% of people over 40 years of age worldwide have been diagnosed with knee osteoarthritis. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Thus rising geriatric population in the region is further escalating the market growth. In addition, Rising number of sports injuries and development of Personalized medicines for osteoarthritis is creating a lucrative growth to the market. However, Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment and Commercialization of alternatives may hamper the market growth.

The key regions considered for the Global Osteoarthritis Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of key market players and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Pfizer, Inc
  • Eli Lilly and Company
  • Horizon Therapeutics plc
  • Ferring B.V.
  • Merck Sharp & Dohme Corp.
  • GlaxoSmithKline Plc.
  • Johnson & Johnson Private Limited
  • Bayer AG
  • Novartis AG
  • Pacira Pharmaceuticals, Inc

Recent Developments in the Market:

  • In January 2023, Arugula Sciences, LLC announced that it had received FDA permission for a Phase 1 clinical trial in the US for its first therapeutic product, Signature Cord PrimeTM. This was accomplished in partnership with its clinical partners. For patients with symptomatic knee osteoarthritis, this Phase 1 research is an open-label, dosage-ranging evaluation of safety, tolerability, preliminary effectiveness, and dose effects.
  • In February 2022, Alkem Laboratories announced that the Drug Controller General of India (DCGI) had approved the marketing of StemOne in India. The product is suggested for a variety of conditions, including knee osteoarthritis. It is the first allogeneic cell therapy product to be given commercial approval in India for the treatment of osteoarthritis of the knee.

Global Osteoarthritis Therapeutics Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Anatomy, Drug Type, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Anatomy offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Anatomy:

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis
  • Small Joint Osteoarthritis

By Drug Type:

  • Viscosupplementation Agents
  • Non-steroidal Anti-inflammatory Drugs
  • Analgesics
  • Corticosteroids

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Osteoarthritis Therapeutics Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Osteoarthritis Therapeutics Market, by Anatomy , 2019-2029 (USD Million)
    • 1.2.3. Osteoarthritis Therapeutics Market, by Drug Type, 2019-2029 (USD Million)
    • 1.2.4. Osteoarthritis Therapeutics Market, by Distribution Channel, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Osteoarthritis Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Osteoarthritis Therapeutics Market Dynamics

  • 3.1. Osteoarthritis Therapeutics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of osteoarthritis
      • 3.1.1.2. Growing population susceptible to osteoarthritis
    • 3.1.2. Market Challenges
      • 3.1.2.1. Risk of adverse cardiovascular events associated with the use of NSAIDs
      • 3.1.2.2. Commercialization of alternatives
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising number of sports injuries
      • 3.1.3.2. Development of Personalized medicines

Chapter 4. Global Osteoarthritis Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Osteoarthritis Therapeutics Market, by Anatomy

  • 6.1. Market Snapshot
  • 6.2. Global Osteoarthritis Therapeutics Market by Anatomy , Performance - Potential Analysis
  • 6.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Anatomy 2019-2029 (USD Million)
  • 6.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Knee Osteoarthritis
    • 6.4.2. Hip Osteoarthritis
    • 6.4.3. Hand Osteoarthritis
    • 6.4.4. Small Joint Osteoarthritis

Chapter 7. Global Osteoarthritis Therapeutics Market, by Drug Type

  • 7.1. Market Snapshot
  • 7.2. Global Osteoarthritis Therapeutics Market by Drug Type, Performance - Potential Analysis
  • 7.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Drug Type 2019-2029 (USD Million)
  • 7.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Viscosupplementation Agents
    • 7.4.2. Non-steroidal Anti-inflammatory Drugs
    • 7.4.3. Analgesics
    • 7.4.4. Corticosteroids

Chapter 8. Global Osteoarthritis Therapeutics Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Osteoarthritis Therapeutics Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
  • 8.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
    • 8.4.1. Hospitals Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Osteoarthritis Therapeutics Market, Regional Analysis

  • 9.1. Osteoarthritis Therapeutics Market, Regional Market Snapshot
  • 9.2. North America Osteoarthritis Therapeutics Market
    • 9.2.1. U.S. Osteoarthritis Therapeutics Market
      • 9.2.1.1. Anatomy breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Osteoarthritis Therapeutics Market
  • 9.3. Europe Osteoarthritis Therapeutics Market Snapshot
    • 9.3.1. U.K. Osteoarthritis Therapeutics Market
    • 9.3.2. Germany Osteoarthritis Therapeutics Market
    • 9.3.3. France Osteoarthritis Therapeutics Market
    • 9.3.4. Spain Osteoarthritis Therapeutics Market
    • 9.3.5. Italy Osteoarthritis Therapeutics Market
    • 9.3.6. Rest of Europe Osteoarthritis Therapeutics Market
  • 9.4. Asia-Pacific Osteoarthritis Therapeutics Market Snapshot
    • 9.4.1. China Osteoarthritis Therapeutics Market
    • 9.4.2. India Osteoarthritis Therapeutics Market
    • 9.4.3. Japan Osteoarthritis Therapeutics Market
    • 9.4.4. Australia Osteoarthritis Therapeutics Market
    • 9.4.5. South Korea Osteoarthritis Therapeutics Market
    • 9.4.6. Rest of Asia Pacific Osteoarthritis Therapeutics Market
  • 9.5. Latin America Osteoarthritis Therapeutics Market Snapshot
    • 9.5.1. Brazil Osteoarthritis Therapeutics Market
    • 9.5.2. Mexico Osteoarthritis Therapeutics Market
    • 9.5.3. Rest of Latin America Osteoarthritis Therapeutics Market
  • 9.6. Rest of The World Osteoarthritis Therapeutics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Pfizer, Inc
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Eli Lilly and Company
    • 10.2.3. Horizon Therapeutics plc
    • 10.2.4. Ferring B.V.
    • 10.2.5. Merck Sharp & Dohme Corp.
    • 10.2.6. GlaxoSmithKline Plc.
    • 10.2.7. Johnson & Johnson Private Limited
    • 10.2.8. Bayer AG
    • 10.2.9. Novartis AG
    • 10.2.10. Pacira Pharmaceuticals, Inc

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption